We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





First Ever COVID-19 Portable Sweat Test Device Delivers Results in 30 Seconds

By LabMedica International staff writers
Posted on 13 Sep 2021
A first-ever COVID-19 portable sweat test device can yield instant results and could support proactive screening in the community.

Researchers at Chulalongkorn University (Bangkok, Thailand) have successfully developed, for the first time, a quick and easy-to-use portable sweat test device for COVID-19 to detect specific scents in sweat caused by bacteria. More...
Sample collection only takes 15 minutes per person, and the results can be obtained in 30 seconds. The sweat test is now being used in community screening. The test is based on the success of the “COVID-19 Sniffer Dogs” project that uses sweat sniffer dogs to detect asymptomatic COVID-19 cases in the community.

People’s sweat may have more than 100 unique scents — be it from the powder, roll-on deodorant, or the bacteria that feed on sweat or skin secretions, then excrete the substances that are mixed with sweat. The portable sweat test device was developed from a commercially available portable chemistry analyzer which is generally used to measure chemicals that are toxic to the environment. To adapt it to detect COVID-19, the researchers installed a specific filter to detect the virus. The advantage of this method is that it can be adapted to detect mutated variants of the virus or other microorganisms. Field tests of the device on 2,000 people alongside the PCR (Polymerase Chain Reaction) testing found the results to be on a par – with 95% sensitivity and 98% specificity.

“For those infected with COVID-19, the bacteria react abnormally to the virus and produce some distinct odors unique to COVID-19 infection,” explained Asst. Prof. Dr. Chadin Kulsing, Department of Chemistry, Faculty of Science, Chulalongkorn University. “The test kit consists of a glass vial and a cotton swab which screeners will receive one each. The screeners would place the cotton swab under the armpit of the person receiving the test and leave it for about 15 minutes. After that, the cotton swab is put in the glass vile, which is then sterilized with UV rays. The technician then draws an appropriate amount of the sample using a suction hose, and pressurizes it into the analyzer to check the results.”

Related Links:
Chulalongkorn University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The automated multiplex PCR assay runs on the BioFire Spotfire Vaginitis System, bringing molecular vaginitis testing to the point of care (Photo courtesy of bioMérieux)

Molecular Vaginitis Panel Gains FDA Clearance and CLIA Waiver for Point-of-Care Use

Vaginitis affects most women at least once in their lifetime and can cause painful, disruptive symptoms. Common causes include bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis, reflecting... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: The CE-marked software IVD combines digital histopathology and clinicopathological data to generate a prognostic classification (Image Credit: Shutterstock)

Digital Pathology Test Stratifies Recurrence Risk in Early Breast Cancer

In hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer, accurate recurrence-risk assessment helps guide treatment decisions. However, individual risks... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: The integration with FlexLab X brings the Panther System into fully tracked automation environments to increase capacity, traceability, and workflow efficiency (Photo courtesy of Hologic)

Hologic and Inpeco Partner to Advance Molecular Laboratory Automation in Europe

Hologic, Inc. (Marlborough, MA, USA) and Inpeco S.A. (Novazzano, Switzerland) have signed a co-marketing partnership in Europe for Inpeco’s recently launched FlexLab X automation solution and Hologic’s... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.